The correlates of benefit from neoadjuvant chemotherapy before surgery in non-small-cell lung cancer: a metaregression analysis


Creative Commons License

Bozcuk H., Abalı H., Çoşkun Ş., Aydıner A., Çinkaya A., Demirkazık A., ...More

WORLD JOURNAL OF SURGICAL ONCOLOGY, vol.10, 2012 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 10
  • Publication Date: 2012
  • Doi Number: 10.1186/1477-7819-10-161
  • Title of Journal : WORLD JOURNAL OF SURGICAL ONCOLOGY
  • Keywords: Meta-analysis, Metaregression, Mortality, Neoadjuvant chemotherapy, Non-small-cell lung cancer, COMPARING PERIOPERATIVE CHEMOTHERAPY, INDUCTION CHEMOTHERAPY, PLUS SURGERY, METAANALYSIS, GEMCITABINE, CARCINOMA

Abstract

Background: Although neoadjuvant chemotherapy (NCT) is widely used, it is not clear which subgroup of locally advanced non-small-cell lung cancer (NSCLC) patients should be treated with this approach, and if a particular benefit associated with NCT exists. In this study, we aimed to investigate the potential correlates of benefit from NCT in patients with NSCLC.